Summary of Purpose
This is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period.Read More →
The following dates are available for this trial. Trial information last updated on 6 June 2017.
|1 Jul 2017||23 May 2017||1 Feb 2018||1 Aug 2018||1 Jun 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allogeneic umbilical cord mesenchymal stem cell
- Aspirin Enteric-coated Tablets & Atorvastatin Calcium